Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ioanna Zografou

Showing results (1-10 of 33) with videos related to

Pageof 4
Sort By:
American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions|September 8, 2023
The Current Place of DPP4 Inhibitors in the Evolving Landscape of Type 2 Diabetes Management: Is It Time to Bid Adieu?Theocharis Koufakis, Ioanna Zografou, Michael Doumas, et al.
Current Vascular Pharmacology|July 26, 2019
Validation of Neuropad in the Assessment of Peripheral Diabetic Neuropathy in Patients with Diabetes Mellitus Versus the Michigan Neuropathy Screening Instrument, 10g Monofilament Application and Biothesiometer MeasurementIoanna Zografou, Fotios Iliadis, Christos Sambanis, et al.
World Journal of Diabetes|May 20, 2024
Drawing lines in the sand: The growing threat of obesity in type 1 diabetesTheocharis Koufakis, Dimitrios Patoulias, Ioanna Zografou, et al.
Current Vascular Pharmacology|April 10, 2019
The Growing Epidemic of Diabetes MellitusDragan Lovic, Alexia Piperidou, Ioanna Zografou, et al.
Current Pharmaceutical Design|October 12, 2018
Multimodal Treatment of Homozygous Familial HypercholesterolemiaThomas Gossios, Ioanna Zografou, Veta Simoulidou, et al.
Medicina (Kaunas, Lithuania)|September 23, 2022
Effect of Empagliflozin and Dapagliflozin on Ambulatory Arterial Stiffness in Patients with Type 2 Diabetes Mellitus and Cardiovascular Co-Morbidities: A Prospective, Observational StudyDimitrios Patoulias, Christodoulos Papadopoulos, Ioanna Zografou, et al.
Journal of Clinical Hypertension (Greenwich, Conn.)|February 15, 2020
Prognostic value of arterial stiffness measurements in cardiovascular disease, diabetes, and its complications: The potential role of sodium-glucose co-transporter-2 inhibitorsDimitrios Patoulias, Christodoulos Papadopoulos, Konstantinos Stavropoulos, et al.
International Journal of Hypertension|November 6, 2019
Effect of Nebivolol and Olmesartan on 24-Hour Brachial and Aortic Blood Pressure in the Acute Stage of Ischemic StrokeEleni Georgianou, Panagiotis I Georgianos, Konstantinos Petidis, et al.
Current Pharmaceutical Design|February 16, 2019
The Mechanisms of Actions of Aldosterone and its Antagonists in Cardiovascular DiseasePanteleimon Pantelidis, Michail Sideris, Margus Viigimaa, et al.
Expert Review of Gastroenterology & Hepatology|February 13, 2018
The potential role of statins in treating liver diseaseKonstantinos P Imprialos, Konstantinos Stavropoulos, Michael Doumas, et al.
Pageof 4

Showing results (1-10 of 33) with videos related to

Sort By:
Pageof 4
American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions|September 8, 2023
The Current Place of DPP4 Inhibitors in the Evolving Landscape of Type 2 Diabetes Management: Is It Time to Bid Adieu?Theocharis Koufakis, Ioanna Zografou, Michael Doumas, et al.
Current Vascular Pharmacology|July 26, 2019
Validation of Neuropad in the Assessment of Peripheral Diabetic Neuropathy in Patients with Diabetes Mellitus Versus the Michigan Neuropathy Screening Instrument, 10g Monofilament Application and Biothesiometer MeasurementIoanna Zografou, Fotios Iliadis, Christos Sambanis, et al.
World Journal of Diabetes|May 20, 2024
Drawing lines in the sand: The growing threat of obesity in type 1 diabetesTheocharis Koufakis, Dimitrios Patoulias, Ioanna Zografou, et al.
Current Vascular Pharmacology|April 10, 2019
The Growing Epidemic of Diabetes MellitusDragan Lovic, Alexia Piperidou, Ioanna Zografou, et al.
Current Pharmaceutical Design|October 12, 2018
Multimodal Treatment of Homozygous Familial HypercholesterolemiaThomas Gossios, Ioanna Zografou, Veta Simoulidou, et al.
Medicina (Kaunas, Lithuania)|September 23, 2022
Effect of Empagliflozin and Dapagliflozin on Ambulatory Arterial Stiffness in Patients with Type 2 Diabetes Mellitus and Cardiovascular Co-Morbidities: A Prospective, Observational StudyDimitrios Patoulias, Christodoulos Papadopoulos, Ioanna Zografou, et al.
Journal of Clinical Hypertension (Greenwich, Conn.)|February 15, 2020
Prognostic value of arterial stiffness measurements in cardiovascular disease, diabetes, and its complications: The potential role of sodium-glucose co-transporter-2 inhibitorsDimitrios Patoulias, Christodoulos Papadopoulos, Konstantinos Stavropoulos, et al.
International Journal of Hypertension|November 6, 2019
Effect of Nebivolol and Olmesartan on 24-Hour Brachial and Aortic Blood Pressure in the Acute Stage of Ischemic StrokeEleni Georgianou, Panagiotis I Georgianos, Konstantinos Petidis, et al.
Current Pharmaceutical Design|February 16, 2019
The Mechanisms of Actions of Aldosterone and its Antagonists in Cardiovascular DiseasePanteleimon Pantelidis, Michail Sideris, Margus Viigimaa, et al.
Expert Review of Gastroenterology & Hepatology|February 13, 2018
The potential role of statins in treating liver diseaseKonstantinos P Imprialos, Konstantinos Stavropoulos, Michael Doumas, et al.
Pageof 4